GE Healthcare^® Poster Competition

The Most Therapeutic Potential

GE Healthcare® is generously providing a grant to support a competition with cash prizes for the three best posters at the 15th International Conference. The first poster competition was held at the 9th International Conference, where three representatives of the Inflammation Research Association Board formed the judging panel to select those posters describing work with “the most therapeutic potential.” Monetary prizes at the 14th International Conference at the Hyatt Regency Chesapeake Bay, Cambridge, MD were awarded at the closing banquet on October 18, 2006.

2006 Poster Competition Award Winners

First Prize | First prize of $2500, for the poster representing research with the most therapeutic potential was awarded to William F. Westlin and his colleagues from Praecis Pharmaceuticals for Poster A162 entitled: Disease-modifying activity in a model of rheumatoid arthritis with an orally available inhibitor of methionine aminopeptidase type-2, PPI-2458.

Second Prize | Second prize of $1000 went to the authors of Poster A129, authored by Patrice Lee et al, a team of scientists from Array Biopharma and Lovelace Respiratory Research Institute for their work entitled: Effects of a p38 MAP kinase inhibitor in an animal model of pulmonary inflammation via intratracheal or inhaled delivery.

Third Prize | Philip Low (Endocyte) and co-workers at Purdue University and Endocyte were awarded the Third prize ($500) for Poster A133: Selective targeting of drugs to activated macrophages: use in imaging and therapy of inflammatory diseases.

Rules of Eligibility

Scientific posters that have been accepted by the IRA into the official General Poster Sessions are eligible (excluding Van Arman finalists), and are automatically entered into the competition. Authors selected for Mini-symposia presentations have the option of also preparing a poster, which will then be entered into the competition.

Employees of GE Healthcare® or any of its subsidiaries are not eligible to enter.

The judging panel will only recognize work that has not been previously published.

Procedures for Entry

To participate in the competition, eligible contestants should submit an abstract on the form included in the online Registration Materials.

Abstracts accepted by the IRA for display as scientific posters at the meeting will be automatically entered into the competition (excluding Van Arman finalists).

Abstracts must be submitted in English.

Deadline for Entry

The deadline, as stated on the abstract form, is June 1, 2008. Abstracts received after this date will NOT be published/eligible.

Judging Procedures

Five representatives of the IRA will form the judging panel. They will award a 1st, 2nd, and 3rd prize to the posters that, in their opinion, describe work which has the most therapeutic potential. The decision of the judges is final.

Prizes

The judges will announce three prizes at the Conference Banquet on September 23, 2008.

1st prize $2500
2nd prize $1000
3rd prize $500

Prize winners will be awarded certificates and prizes at the Banquet.

^ TOP of PAGE